Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2025-12-24 @ 10:08 PM
NCT ID:
NCT04712435
Eligibility Criteria:
Inclusion Criteria:
* Men or women
* Age ≥ 18 years
* A proven diagnosis of one of the hematological malignancies: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Chronic Myeloid Leukemia, Chronic Lymphoid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma
* Patients must be scheduled to undergo of Allogeneic hematopoietic transplantation or HLA (Human Leukocyte Antigen) haploidentical related or Unrelated or HLA-matched related or autologous stem cell transplant
* Patients must be able to understand and sign a written informed consent
Exclusion Criteria:
* Patient has a serious active disease or co-morbid medical condition, as judged by the investigator, which would interfere with the conduct of this study
* Patient, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
* Known hypersensitivity to N-acetylcysteine
* Contraindications to perform any procedure provided for in this study
* Patients who have already undergone a previous transplant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04712435
Study Brief:
Protocol Section:
NCT04712435